Exact Mass: 715.3601

Exact Mass Matches: 715.3601

Found 22 metabolites which its exact mass value is equals to given mass value 715.3601, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Saquinavir-NO

N-{4-[3-(tert-butyl-C-hydroxycarbonimidoyl)-decahydroisoquinolin-2-yl]-3-(nitrooxy)-1-phenylbutan-2-yl}-2-[(quinolin-2-yl)formamido]butanediimidate

C38H49N7O7 (715.3693)


   

3-Acetyl-15-veratroylgermine

3-Acetyl-15-veratroylgermine

C38H53NO12 (715.3568)


   

Phe Gln Phe Phe Lys

Phe Gln Phe Phe Lys

C38H49N7O7 (715.3693)


   

Phenalinolactone A

Phenalinolactone A

C38H53NO12 (715.3568)


   

FQFFK

Phe Gln Phe Phe Lys

C38H49N7O7 (715.3693)


   

H-Gly-Arg-Gly-Asp-Ser-Pro-Lys-OH acetate salt

H-Gly-Arg-Gly-Asp-Ser-Pro-Lys-OH acetate salt

C28H49N11O11 (715.3613)


GRGDSPK (EMD 56574) is a peptide incluing Arg-Gly-Asp (RGD). GRGDSPK (EMD 56574) is an competitive and reversible inhibitory peptide for inhibiting integrin-fibronectin binding. GRGDSPK is used to study the role of integrins in bone formation and resorption[1][2].

   

N-{4-[3-(tert-butylcarbamoyl)-octahydro-1H-isoquinolin-2-yl]-3-(nitrooxy)-1-phenylbutan-2-yl}-2-(quinolin-2-ylformamido)succinamide

N-{4-[3-(tert-butylcarbamoyl)-octahydro-1H-isoquinolin-2-yl]-3-(nitrooxy)-1-phenylbutan-2-yl}-2-(quinolin-2-ylformamido)succinamide

C38H49N7O7 (715.3693)


   

Human neocasomorphin(1-)

Human neocasomorphin(1-)

C35H51N6O10- (715.3666)


   
   
   

neocasomorphin(1-)

neocasomorphin(1-)

C35H51N6O10 (715.3666)


A peptide anion obtained from the deprotonation of the two carboxy groups, and protonation of the primary amino group of neocasomorphin. It is the major species at pH 7.3.

   
   

PS P-18:1/11:4;O3

PS P-18:1/11:4;O3

C35H58NO12P (715.3696)


   
   
   
   
   
   
   

[2-(acetyloxy)-8-(2,4-dihydroxy-5-oxo-2h-furan-3-yl)-4-hydroxy-1-{[(5-methoxy-6-methyloxan-2-yl)oxy]methyl}-4a,7,8a-trimethyl-3,4,4b,5,8,9,10,10a-octahydro-2h-phenanthren-1-yl]methyl 5-methyl-1h-pyrrole-2-carboxylate

[2-(acetyloxy)-8-(2,4-dihydroxy-5-oxo-2h-furan-3-yl)-4-hydroxy-1-{[(5-methoxy-6-methyloxan-2-yl)oxy]methyl}-4a,7,8a-trimethyl-3,4,4b,5,8,9,10,10a-octahydro-2h-phenanthren-1-yl]methyl 5-methyl-1h-pyrrole-2-carboxylate

C38H53NO12 (715.3568)


   

[(1r,2r,4s,4as,4br,8r,8ar)-2-(acetyloxy)-8-(2,4-dihydroxy-5-oxo-2h-furan-3-yl)-4-hydroxy-1-{[(5-methoxy-6-methyloxan-2-yl)oxy]methyl}-4a,7,8a-trimethyl-3,4,4b,5,8,9,10,10a-octahydro-2h-phenanthren-1-yl]methyl 5-methyl-1h-pyrrole-2-carboxylate

[(1r,2r,4s,4as,4br,8r,8ar)-2-(acetyloxy)-8-(2,4-dihydroxy-5-oxo-2h-furan-3-yl)-4-hydroxy-1-{[(5-methoxy-6-methyloxan-2-yl)oxy]methyl}-4a,7,8a-trimethyl-3,4,4b,5,8,9,10,10a-octahydro-2h-phenanthren-1-yl]methyl 5-methyl-1h-pyrrole-2-carboxylate

C38H53NO12 (715.3568)


   

[(2r,4s,4as,4br,8r,8ar,10as)-2-(acetyloxy)-8-(2,4-dihydroxy-5-oxo-2h-furan-3-yl)-4-hydroxy-1-({[(2r,5r,6s)-5-methoxy-6-methyloxan-2-yl]oxy}methyl)-4a,7,8a-trimethyl-3,4,4b,5,8,9,10,10a-octahydro-2h-phenanthren-1-yl]methyl 5-methyl-1h-pyrrole-2-carboxylate

[(2r,4s,4as,4br,8r,8ar,10as)-2-(acetyloxy)-8-(2,4-dihydroxy-5-oxo-2h-furan-3-yl)-4-hydroxy-1-({[(2r,5r,6s)-5-methoxy-6-methyloxan-2-yl]oxy}methyl)-4a,7,8a-trimethyl-3,4,4b,5,8,9,10,10a-octahydro-2h-phenanthren-1-yl]methyl 5-methyl-1h-pyrrole-2-carboxylate

C38H53NO12 (715.3568)